Imaginostics Is Making the Invisible Visible in Vascular Health | Health Moonshot Update
After eight years of translating a physics breakthrough into a clinical product, StartUp Health community members Valerie Gharagouzloo, CEO & Co-founder, and Codi Gharagouzloo, PhD, Chief Science Officer & Co-founder of Imaginostics, are at an inflection point. With FDA Breakthrough Designation secured, a commercialization partnership with Siemens underway, and a 96-patient biomarker study now in motion, Imaginostics is closing the distance between laboratory invention and bedside impact.
